MMJ Group Holdings Ltd (ASX:MMJ) (OTCMKTS:MMJJF) (FRA:2P9) investee Embark Health Inc has entered into a definitive agreement with Mesa Exploration Corp in regard to a business combination between the two entities.
The transaction will result in a reverse takeover of Mesa by the shareholders of Embark and the outside date for the transaction is set for March 31, 2021.
This will result in MMJ’s investment in Embark being valued using the listed TSX-V price of the listed entity.
On December 7 Embark Health was granted an amendment to its Health Canada licence allowing direct sales of cannabis extracts, cannabis topicals and edible cannabis products from the Embark Delta Inc facility in Delta, British Columbia.
The amendment permits sales of Cannabis 2.0 products directly to Canadian provinces & territories and allows Embark Delta to further expand its existing and future product offerings to the medical and recreational consumer markets with concentrates, extracts and nano-emulsified topical and edible products.
In addition, Embark can now offer white-labelling turn-key manufacturing services to its commercial accounts.
Embark is currently producing Bubble Hash, Dry Sift, Traditional Pressed Hash and Rosin at the Delta facility.
MMJ was a foundation investor in Embark Health in July 2018 with that the investment having a book value of $13.6 million and now comprises: